Objective The purpose of this study was to develop an in-depth understanding of papillary microcarcinoma (PMC) patients' decision-making process when offered options of surgery and active surveillance.
2 decades with comparable outcomes as compared with surgery. 8 For example, findings from observational studies suggest that observing PMC over time carries minimal risk of disease progression and incurs no increase in disease specific mortality in properly selected patients. 4, 9, 10 At the same time, thyroidectomy poses limited risks:
1% to 2% risk of permanently impaired vocal cord function, 2% to 3% risk of permanent hypocalcemia, 1% risk of infection, and a 1% risk of death. 11 Clearly, the objective risks and benefits of surgery versus active surveillance for PMC are similar, and a superior treatment approach is equivocal.
In spite of the updated American Thyroid Association guidelines, it remains unclear whether or not patients in the United States would seriously consider active surveillance as an acceptable management option for PMC. No studies on patients' preference for active surveillance versus surgery have been conducted in the United States.
Patients' choice of treatment in Japanese trials suggests that active surveillance has become increasingly accepted over time. For example, only 24% of enrolled PMC patients opted for active surveillance in 1
Japanese trial between 1993 and 2004. 8 More recent data shows that 55% of patients chose active surveillance when presented with the option. 9 Many patients still appear highly motivated to remove their thyroid when cancer is detected. At the same time, if patients consider the aforementioned minimal risks of disease progression and metastasis in light of surgical risks and other factors, active surveillance may be an appealing alternative.
To the best of our knowledge, no empirical studies have examined treatment decision making among PMC patients. Such a gap in the literature is problematic given the dramatic rise in the number of Americans diagnosed with PMC over the past several decades and that an increasing number of PMC patients in the United States will be faced with a choice between active surveillance and surgery as a result of the newly released treatment guidelines. 6 Research investigating how PMC patients weigh the risks and benefits of initial treatment options is a crucial first step in determining how to best meet the informational needs of this unique cancer population and aid in informed decision making. The purpose of this qualitative study was to develop an indepth understanding of PMC patients' decision-making approach when offered a choice between active surveillance and surgery.
2 | METHODS
| Recruitment and data collection
Participants were recruited from an endocrinology outpatient clinic at Memorial Sloan Kettering Cancer Center. Eligible participants were (1) diagnosed with PMC within the past year; (2) offered treatment options of active surveillance and surgery; (3) English speaking; and (4) greater than 18 years. A total of 33 patients were approached, and 15 agreed to participate (acceptance rate = 45.5%). Patients' primary reasons for study refusal included lack of interest, significant geographic distance from the study site, being too busy, and too anxious to discuss their illness.
Enrolled patients were asked if they would like to nominate a caregiver who assisted their decision-making process to also participate.
We included caregivers for 2 reasons. First, it is well established that a cancer diagnosis profoundly impacts not only the patient but also his or her family members. 12, 13 Second, cancer patients do not make treatment decisions in isolation. Caregivers frequently attend oncology appointments and help patients with their decision-making process.
14 For these reasons, we believed that caregivers held an important perspective on how patients approached decision making and arrived at a treatment choice. Six caregivers were nominated and enrolled in this study. Therefore, the total sample included 21 participants. This study was approved by the Institutional Review Board at our institution (registration number 00000273), and informed consent was obtained from all participants. Each participant was compensated $50 for their time.
After consenting to the study, participants were scheduled for a focus group. Individual interviews were offered as an alternative to individuals who were unable to attend any of the scheduled focus groups. We believed that this option would help address barriers to participation and therefore improve accrual rates. We segmented the focus groups by patients' treatment choice, either surgery or active surveillance. Caregivers were interviewed alongside the patient who had nominated them. A total of 3 focus groups (1 surgery and 2 active surveillance) and 7 individual interviews (2 surgery and 5 active surveillance) were conducted. Of the 15 PMC patients who participated in the study in total (across both focus groups and individual interviews), 4 were from the surgery subsample and 11 were from the active surveillance subsample. Of the 6 caregivers who took part in the study, 3 were from the surgery subsample and 3 were from the active surveillance subsample.
A qualitative method specialist (ES) moderated each focus group. 
| Data analysis
The fellow analyzed all transcripts using thematic text analysis. 15, 16 The ATLAS.ti program was used to organize and analyze all data. uncover the properties of a thematic category and allow for development of rules regarding thematic category assignment. 18 As coding became more rule oriented, an iterative process of identifying, defining, testing, and refining thematic categories was used. 19 In the final phase of coding, fewer and fewer modifications to thematic categories were made, and memos reflected the overarching scope of understanding concerning the structure of the decision-making process for the active surveillance and surgery subsamples. In addition, similarities and differences in treatment decision-making processes between the subsamples were noted. analysis. 20 Sixteen participants completed a follow-up interview, including 12 patients and 4 caregivers. Overall, participants who completed a follow-up interview reported that the findings were consistent with their experience. Therefore, no themes were added or modified based on the member check.
3 | RESULTS
| Study sample
Patients ranged in age from 29 to 69 years old (mean = 48.3 y).
Patients were predominately female, white, married, educated beyond high school, and diagnosed within the previous 6 months. Caregivers ranged in age from 31 to 81 years old (mean = 53.2 y) and were all white males. Caregivers were predominately married and educated with a postgraduate degree. Full demographics are presented in Tables 1 and 2 .
| Emergent themes
Four primary themes emerged from analysis of the surgery subsample transcripts, and 3 themes were identified during analysis of the active surveillance subsample transcripts. In addition, 2 themes emerged that were shared by participants from both treatment subsamples. Themes and supporting quotes are presented in Table 3 . Perception of PMC as a potentially life-threatening disease.
Surgery participants expressed a strong set of cancer-related beliefs, Perception of PMC as a potentially life-threatening disease "Cancer is cancer."
Fear of disease progression and unremitting uncertainty with active surveillance "Watching could literally be deadly."
Surgery as a means of control and potential cure "Every doctor made it sound as if after the surgery that's it. This one's treatable, curable. Just take it out and that's it."
Active Surveillance Subsample
View of PMC as a common, indolent, and low-risk disease "…it's the slowest growing. It doesn't spread quickly…it really takes a lot of neglect for it to really get rampant, if at all."
Concerns about adjusting to life without a thyroid and becoming reliant on hormone replacement medication "…your thyroid is not your tonsils. It's not your appendix…it's an important part of your body…" Openness to reconsidering surgery over the long run "I have an optimistic attitude about things too and say, well let me see. You can always go for the surgery when things get worse."
Common Themes Between Subsamples
Deep level of trust and confidence in physician and cancer center
Surgery: "For him it's a Tuesday morning. It's, 'I've done these my whole life. It's no big deal. We'll get you in, we'll get you out.' And that's that." Active surveillance: "He sees these things every single day…He experiments on these things and he would know if it was going to grow fast."
Use of physician and internet as primary sources of disease and treatment-related information Surgery: "We relied on Dr.
[X] a lot. He definitely calmed me down and he provided a lot of information about thyroid cancer and the surgery." Active surveillance: "Really just Dr.
[Y]. He is the one I really trust and so he is the one who told me about everything."
Abbreviation: PMC, papillary microcarcinoma.
expectations, and fears. Positive framing of PMC (ie, describing PMC as a "good cancer") provided some relief, but any comfort related to the specific diagnosis was overshadowed by these participants' negative views of cancer in general. As one participant stated, "Just the word 'cancer' is scary." Such underlying views were informed by a personal history of another cancer or an experience of loss involving cancer (eg, one participant lost her brother to leukemia at a young age).
As such, any type of cancer was seen as something that should be feared and treated aggressively. The appraisal and management of uncertainty were inherent in the decision-making process of participants from both PMC treatment subsamples. As such, the Uncertainty in Illness Theory 34, 35 can help conceptualize our findings. Uncertainty is defined as an inability to construct meaning or accurately predict outcomes based on illnessrelated stimuli that are ambiguous, complex, and unpredictable. 
| Study limitations
Some limitations of this study should be considered. The lack of diversity in our sample limits the transferability of findings. It is possible that 
| Clinical implications
Our results suggest that PMC patients' decision-making process is greatly influenced by the experience and management of uncertainty.
Moreover, surgery and active surveillance appear to offer distinct benefits that are best matched to the unique concerns and focus of different groups of PMC patients. Since a superior treatment is equivocal, it is crucial that physicians remain flexible and responsive to the needs, preferences, and concerns of individual PMC patients. 38, 39 Physicians must develop an understanding of patients' values, preferences, goals, and beliefs to guide clinical recommendations and provide information and support. Physicians should also be prepared to discuss the features and potential complications of surgery and active surveillance.
Through such steps, physicians can help PMC patients navigate the difficult decision-making process and arrive at a treatment choice that they are comfortable with.
| CONCLUSION
This study represents the first step in understanding the treatment decision-making process of PMC patients. Our work is timely, given that an increasing number of PMC patients in the United States will be faced with a choice between active surveillance and surgery. Although caregivers were invited to accompany patients, we asked them to comment and reflect on patients' decision-making process.
Future work should focus specifically on the role and unique perspective of caregivers, perhaps interviewing family members and significant others in isolation. We hope that these findings will stimulate work toward the ultimate goal of producing materials to meet the informational needs of PMC patients and to aid in informed decision making.
